Abstract 20322: Extended-Duration Betrixaban Reduces the Risk of Venous Thromboembolism-Related Rehospitalization Among Acutely Ill Hospitalized Medical Patients: An APEX Trial Substudy.
Journal article published in 2017 by
Gerald Chi 
,
Tarek Nafee,
Samuel Z. Goldhaber,
Adrian F. Hernandez,
Russell D. Hull,
Alex Gold,
Serge Korjian,
Yazan Daaboul,
Alexander T. Cohen,
Robert A. Harrington
,
Tarek Nafee,
Samuel Z. Goldhaber,
Adrian F. Hernandez,
Russell D. Hull,
Alex Gold,
Serge Korjian,
Yazan Daaboul,
Alexander T. Cohen,
Robert A. Harrington
